173 related articles for article (PubMed ID: 32315751)
1. Nanoparticle albumin-bound mTHPC for photodynamic therapy: Preparation and comprehensive characterization of a promising drug delivery system.
Stein NC; Mulac D; Fabian J; Herrmann FC; Langer K
Int J Pharm; 2020 May; 582():119347. PubMed ID: 32315751
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of mTHPC-loaded solid lipid nanoparticles for photodynamic therapy.
Navarro FP; Creusat G; Frochot C; Moussaron A; Verhille M; Vanderesse R; Thomann JS; Boisseau P; Texier I; Couffin AC; Barberi-Heyob M
J Photochem Photobiol B; 2014 Jan; 130():161-9. PubMed ID: 24333764
[TBL] [Abstract][Full Text] [Related]
3. Photosensitizer loaded HSA nanoparticles. I: Preparation and photophysical properties.
Wacker M; Chen K; Preuss A; Possemeyer K; Roeder B; Langer K
Int J Pharm; 2010 Jun; 393(1-2):253-62. PubMed ID: 20417701
[TBL] [Abstract][Full Text] [Related]
4. Wavelength dependent photo-cytotoxicity to ovarian carcinoma cells using temoporfin loaded tetraether liposomes as efficient drug delivery system.
Ali S; Amin MU; Ali MY; Tariq I; Pinnapireddy SR; Duse L; Goergen N; Wölk C; Hause G; Jedelská J; Schäfer J; Bakowsky U
Eur J Pharm Biopharm; 2020 May; 150():50-65. PubMed ID: 32151728
[TBL] [Abstract][Full Text] [Related]
5. Photosensitizer loaded HSA nanoparticles II: in vitro investigations.
Preuss A; Chen K; Hackbarth S; Wacker M; Langer K; Röder B
Int J Pharm; 2011 Feb; 404(1-2):308-16. PubMed ID: 21094228
[TBL] [Abstract][Full Text] [Related]
6. Photocytotoxicity of mTHPC (temoporfin) loaded polymeric micelles mediated by lipase catalyzed degradation.
Hofman JW; Carstens MG; van Zeeland F; Helwig C; Flesch FM; Hennink WE; van Nostrum CF
Pharm Res; 2008 Sep; 25(9):2065-73. PubMed ID: 18597164
[TBL] [Abstract][Full Text] [Related]
7. Magnetic Targeting of mTHPC To Improve the Selectivity and Efficiency of Photodynamic Therapy.
Haimov-Talmoud E; Harel Y; Schori H; Motiei M; Atkins A; Popovtzer R; Lellouche JP; Shefi O
ACS Appl Mater Interfaces; 2019 Dec; 11(49):45368-45380. PubMed ID: 31755692
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic effects of mTHPC on human colon adenocarcinoma cells: photocytotoxicity, subcellular localization and apoptosis.
Leung WN; Sun X; Mak NK; Yow CM
Photochem Photobiol; 2002 Apr; 75(4):406-11. PubMed ID: 12003131
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of mTHPC-loaded PLGA nanoparticles for in vitro photodynamic therapy on C6 glioma cell line.
Bœuf-Muraille G; Rigaux G; Callewaert M; Zambrano N; Van Gulick L; Roullin VG; Terryn C; Andry MC; Chuburu F; Dukic S; Molinari M
Photodiagnosis Photodyn Ther; 2019 Mar; 25():448-455. PubMed ID: 30708089
[TBL] [Abstract][Full Text] [Related]
10. Beta-carotene-bound albumin nanoparticles modified with chlorin e6 for breast tumor ablation based on photodynamic therapy.
Phuong PTT; Lee S; Lee C; Seo B; Park S; Oh KT; Lee ES; Choi HG; Shin BS; Youn YS
Colloids Surf B Biointerfaces; 2018 Nov; 171():123-133. PubMed ID: 30025374
[TBL] [Abstract][Full Text] [Related]
11. Nanocarriers for photodynamic therapy-rational formulation design and medium-scale manufacture.
Villa Nova M; Janas C; Schmidt M; Ulshoefer T; Gräfe S; Schiffmann S; de Bruin N; Wiehe A; Albrecht V; Parnham MJ; Luciano Bruschi M; Wacker MG
Int J Pharm; 2015 Aug; 491(1-2):250-60. PubMed ID: 26123822
[TBL] [Abstract][Full Text] [Related]
12. EGFR-Targeted Nanobody Functionalized Polymeric Micelles Loaded with mTHPC for Selective Photodynamic Therapy.
Liu Y; Scrivano L; Peterson JD; Fens MHAM; Hernández IB; Mesquita B; Toraño JS; Hennink WE; van Nostrum CF; Oliveira S
Mol Pharm; 2020 Apr; 17(4):1276-1292. PubMed ID: 32142290
[No Abstract] [Full Text] [Related]
13. Interaction of liposomal formulations of meta-tetra(hydroxyphenyl)chlorin (temoporfin) with serum proteins: protein binding and liposome destruction.
Reshetov V; Zorin V; Siupa A; D'Hallewin MA; Guillemin F; Bezdetnaya L
Photochem Photobiol; 2012; 88(5):1256-64. PubMed ID: 22607362
[TBL] [Abstract][Full Text] [Related]
14. Development of different temoporfin-loaded invasomes-novel nanocarriers of temoporfin: characterization, stability and in vitro skin penetration studies.
Dragicevic-Curic N; Scheglmann D; Albrecht V; Fahr A
Colloids Surf B Biointerfaces; 2009 May; 70(2):198-206. PubMed ID: 19188048
[TBL] [Abstract][Full Text] [Related]
15. Effect of stroma on the behavior of temoporfin-loaded lipid nanovesicles inside the stroma-rich head and neck carcinoma spheroids.
Yakavets I; Francois A; Lamy L; Piffoux M; Gazeau F; Wilhelm C; Zorin V; Silva AKA; Bezdetnaya L
J Nanobiotechnology; 2021 Jan; 19(1):3. PubMed ID: 33407564
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticulate carriers for photodynamic therapy of cholangiocarcinoma: In vitro comparison of various polymer-based nanoparticles.
Grünebaum J; Söbbing J; Mulac D; Langer K
Int J Pharm; 2015 Dec; 496(2):942-52. PubMed ID: 26456264
[TBL] [Abstract][Full Text] [Related]
17. Comparative characterization of the efficiency and cellular pharmacokinetics of Foscan- and Foslip-based photodynamic treatment in human biliary tract cancer cell lines.
Kiesslich T; Berlanda J; Plaetzer K; Krammer B; Berr F
Photochem Photobiol Sci; 2007 Jun; 6(6):619-27. PubMed ID: 17549263
[TBL] [Abstract][Full Text] [Related]
18. Preparation of a chlorophyll derivative and investigation of its photodynamic activities against cholangiocarcinoma.
Wu ZM; Wang L; Zhu W; Gao YH; Wu HM; Wang M; Hu TS; Yan YJ; Chen ZL
Biomed Pharmacother; 2017 Aug; 92():285-292. PubMed ID: 28551549
[TBL] [Abstract][Full Text] [Related]
19. Inclusion complexation with β-cyclodextrin derivatives alters photodynamic activity and biodistribution of meta-tetra(hydroxyphenyl)chlorin.
Yankovsky I; Bastien E; Yakavets I; Khludeyev I; Lassalle HP; Gräfe S; Bezdetnaya L; Zorin V
Eur J Pharm Sci; 2016 Aug; 91():172-82. PubMed ID: 27320407
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid-conjugated chitosan for photodynamic treatment of HuCC-T1 human cholangiocarcinoma cells.
Lee HM; Jeong YI; Kim DH; Kwak TW; Chung CW; Kim CH; Kang DH
Int J Pharm; 2013 Sep; 454(1):74-81. PubMed ID: 23834828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
